AI-enabled voice technology platform Sonde Health announced it is partnering with Saaya Health, a virtual mental health and well-being platform, to extend its combined offerings to large blue-collar workforces.Sonde Health’s platform uses its patented…
Continue Reading
Clinical trials are an essential component of drug development for new cancer treatments, yet the information required to determine a patient’s eligibility for enrollment is scattered in large amounts of unstructured text. Genomic biomarkers…
Continue Reading
Optical coherence tomography (OCT) is an efficient tool for non-invasively evaluating retinal structures. Retinal thinning changes assessed using OCT are recognized as potential biomarkers for systemic conditions such as Alzheimer’s disease, Parkinson’s disease, and…
Continue Reading
What You Should Know:
– Evvy, a women’s health startup focusing on novel female biomarkers, is embarking on a pioneering study in partnership with leading fertility clinics across the United States.
– The landmark research initiative…
Continue Reading
The rapid increase in real-time health information collected from wearable devices has allowed digital biomarkers to emerge as a promising tool to support perioperative care, including surgical prehabilitation, intra-operative guidance, and post-operative monitoring. Important…
Continue Reading
What You Should Know:
– McKesson has unveiled the Precision Care Companion (PCC), a transformative initiative designed to tackle the multifaceted challenges that healthcare practices face in the rapidly evolving landscape of genomic testing and…
Continue Reading
Traditional sleep staging categorizes sleep and wakefulness into five coarse-grained classes, overlooking subtle variations within each stage. We propose a deep learning method to annotate continuous sleep depth index (SDI) with existing discrete sleep…
Continue Reading
What You Should Know:
– Techmed startup illumicell AI, founded by a team of Harvard-trained physician Michel Bielecki, former McKinsey consultant Jeyla Sadikova, and rocket engineer Loup Cordey, has secured $2M in pre-seed funding. The…
Continue Reading
Preeclampsia (PE), a severe hypertensive disorder during pregnancy, significantly contributes to maternal and neonatal mortality. Existing prediction biomarkers are often invasive and expensive, hindering their widespread application. This study introduces PROMPT (Preeclampsia Risk factor…
Continue Reading
Building accurate prediction models and identifying predictive biomarkers for treatment response in Muscle-Invasive Bladder Cancer (MIBC) are essential for improving patient survival but remain challenging due to tumor heterogeneity, despite numerous related studies. To…
Continue Reading
